News

Video

The IRIS Registry with Gaurav K. Shah, MD, FASRS

Shah discusses several studies from the IRIS registry and plans for a retina program at next year's event to address the growing interest in retina procedures and techniques.

Gaurav K. Shah, MD, FASRS, spoke with Ophthalmology Times at the Glaucoma 360 meeting in San Francisco where he gave a presentation entitled, IRIS Registry: Important Lessons Learned.

In this presentation he discussed several studies from the IRIS registry.The first study examined the success rates of pneumatic retinopexy in pseudophakic versus phakic eyes, finding a high failure rate of one in two in pseudophakic eyes. He noted differences in pneumatic retina packing practices between the US and Canada that could provide lessons.

The second study looked at the removal of retained lens fragments and associated complications. The findings suggested that removal should be done within the first week or even the same day, and placing an IOL may be beneficial in some cases. However, the Shah emphasized the importance of ensuring a clean and stable anterior segment before IOL placement.

The third study focused on high-risk patients with PVD and vitreous hemorrhage. It identified myopia and vitreous hemorrhage as significant risk factors for retinal tears and detachment, and stressed the need for more frequent follow-up in patients with vitreous hemorrhage.

The fourth study addressed the common practice of vitrectomy for floaters, clarifying that it is not a "fluidectomy" but a vitrectomy with significant benefits and risks, including an unexpected 1.6% rate of endophthalmitis. The speaker suggested that while the procedure should not be avoided, it must be performed safely and effectively.

Finally, the Shah looked ahead to next year's Glaucoma 360+ meeting, for which there are plans to develop a comprehensive retina program. The program will cover new retina procedures, implants, and techniques, addressing the growing interest in retina from clinicians, scientists, VCs, and companies.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.